跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
必妥维 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
Approved
化学药品
Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
GILEAD SCIENCES IRELAND UC
🇨🇳 National Medical Products Administration
Approval Date
Apr 16, 2024
Approval ID
8bfYb0HfDQB
Company
GILEAD SCIENCES IRELAND UC
Type
化学药品
Approval Details
Approval Id
8bfYb0HfDQB
Approval Number
国药准字HJ20190047
Generic Name
比克恩丙诺片
Generic Name En
Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
Trade Name
必妥维
Drug Type
化学药品
Dosage Form
片剂
Strength
每片含比克替拉韦钠(以比克替拉韦计)50mg,恩曲他滨200mg,富马酸丙酚替诺福韦(以丙酚替诺福韦计)25mg。
Reg Date
2024-04-16
Expired Date
2029-04-15
Company Name
GILEAD SCIENCES IRELAND UC
Production Company Name
GILEAD SCIENCES IRELAND UC
Company Detail Path
/organization/gilead-sciences-ireland-uc
Production Company Detail Path
/organization/gilead-sciences-ireland-uc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Apr 16, 2024
Approval ID
8bfYb0HfDQB
Type
化学药品
Back to NMPA Approvals